Search
Novartis AG
NVSAdd to Watchlist
154.440USD
-1.700-1.09%
Close 07-23 16:00（ET）Quotes delayed by 15 min
293.55BMarket Cap
21.98P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Rest of portfolio
10.02B
18.37%
Cardiovascular, Renal and Metabolism - Entresto
7.75B
14.21%
Immunology - Cosentyx
6.67B
12.23%
Oncology -Kisqali
4.78B
8.77%
Neuroscience - Kesimpta
4.43B
8.12%
Other
20.89B
38.30%
By RegionUSD
Name
Revenue
Proportion
United States
23.33B
42.78%
Other Foreign-
21.68B
39.76%
China
4.19B
7.68%
Germany
3.94B
7.22%
Switzerland
1.39B
2.56%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Rest of portfolio
10.02B
18.37%
Cardiovascular, Renal and Metabolism - Entresto
7.75B
14.21%
Immunology - Cosentyx
6.67B
12.23%
Oncology -Kisqali
4.78B
8.77%
Neuroscience - Kesimpta
4.43B
8.12%
Other
20.89B
38.30%